0001811468-25-000001.txt : 20250411 0001811468-25-000001.hdr.sgml : 20250411 20250411123707 ACCESSION NUMBER: 0001811468-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250411 DATE AS OF CHANGE: 20250411 EFFECTIVENESS DATE: 20250411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Atsena Therapeutics, Inc. CENTRAL INDEX KEY: 0001811468 ORGANIZATION NAME: EIN: 845181493 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-543461 FILM NUMBER: 25830750 BUSINESS ADDRESS: STREET 1: 8 DAVIS DRIVE, SUITE 300 CITY: DURHAM STATE: NC ZIP: 27709 BUSINESS PHONE: 984-261-2001 MAIL ADDRESS: STREET 1: 8 DAVIS DRIVE, SUITE 300 CITY: DURHAM STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001811468 Atsena Therapeutics, Inc. 8 DAVIS DRIVE, SUITE 300 DURHAM NC NORTH CAROLINA 27709 984-261-2001 DELAWARE VectorEyes Therapeutics, Inc. None Corporation true Patrick Ritschel c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Executive Officer Director Jennifer Wellman c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Jacqueline Grant c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Chris Carpenter c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Christina Isacson c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Joe Zakrzewski c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Norbert Riedel c/o Atsena Therapeutics, Inc. 8 Davis Drive, Suite 300 Durham NC NORTH CAROLINA 27709 Director Biotechnology Decline to Disclose 06b false 2025-03-27 false true false 0 Wedbush Securities Inc. 877 None None 600 Montgomery Street, 29th Floor San Francisco CA CALIFORNIA 94111 CA CALIFORNIA false 150000000 89999975 60000025 false 14 4784981 0 see item 12. Wedbush Securities Inc. 0 false Atsena Therapeutics, Inc. /s/ Patrick Ritschel Patrick Ritschel Chief Executive Officer 2025-04-11